Publications by authors named "Arthur Weaver"

Claim this Profile
C
Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort.
Joseph A Markenson, Andrew S Koenig, Jing Yuan Feng, Sandeep Chaudhari, Debra J Zack, Arthur Weaver

J Clin Rheumatol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatoid arthritis disease activity and disability affect the risk of serious infection events in RADIUS 1.
Arthur Weaver, Orrin Troum, Michele Hooper, Andrew S Koenig, Sandeep Chaudhari

J Rheumatol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging treatments for mild/moderate acute ambulatory pain.
Arthur L Weaver

Am J Ther· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Mild-to-Moderate Acute Pain. Panel discussion.
Bill McCarberg, Robert L Barkin, Leslie Fish, Ronald J Kulich, Louis Kuritzky, Arthur L Weaver

Am J Ther· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How PCP education can impact gout management: the gout essentials.
Arthur L Weaver, Michelle A Cheh, Richard H Kennison

J Clin Rheumatol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: professionals in dialogue: sharing insights and knowledge into gout management.
Arthur L Weaver

J Clin Rheumatol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of gout.
Arthur L Weaver

Cleve Clin J Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989.
Grant W Cannon, Seth H Pincus, Ronald D Emkey, Alex Denes, Selwyn A Cohen, Arthur L Weaver

Arthritis Rheum· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
Stanley B Cohen, Marc D Cohen, John J Cush, Roy M Fleischmann, Philip J Mease, Arthur L Weaver

J Rheumatol Suppl· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the anti-TNF biologic agents.
Arthur L Weaver

Mod Rheumatol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case 1: differential diagnosis of an acute gouty attack.
Arthur L Weaver

Am J Med· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case 3: acute gout-risk factors and inappropriate therapy.
Arthur L Weaver

Am J Med· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
Steven S Smugar, Thomas J Schnitzer, Arthur L Weaver, Bernard R Rubin, Adam B Polis

Curr Med Res Opin· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to expression of concern regarding VIGOR study.
Claire Bombardier, Loren Laine, Ruben Burgos-Vargas, Barry Davis, Richard Day, Arthur Weaver

N Engl J Med· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone.
Arthur L Weaver, Ronald P Messner, William W Storms, Adam B Polis, Daryl K Najarian

J Clin Rheumatol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current state of therapy for pain and inflammation.
Steven B Abramson, Arthur L Weaver

Arthritis Res Ther· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Allan Gibofsky, William R Palmer, John A Goldman, Richard L Lautzenheiser, Joseph A Markenson, Arthur Weaver

Curr Med Res Opin· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Arthur L Weaver, Richard L Lautzenheiser, Michael H Schiff, Allan Gibofsky, James L Perruquet

Curr Med Res Opin· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
Thomas J Schnitzer, Arthur L Weaver, Adam B Polis, Richard A Petruschke, Gregory P Geba

J Rheumatol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
Désirée van der Heijde, Herbert S B Baraf, Cesar Ramos-Remus, Andrei Calin, Arthur L Weaver

Arthritis Rheum· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.
John D Bradley, Alexei A Dmitrienko, Alan J Kivitz, Oscar S Gluck, Arthur L Weaver

J Rheumatol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials.
Wendy P Battisti, Nathaniel P Katz, Arthur L Weaver, Alan K Matsumoto, Alan J Kivitz

J Pain· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis.
Ted R Mikuls, Arthur L Weaver

Curr Rheumatol Rep· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of disease management programs on functional status of patients with rheumatoid arthritis.
Enkhe Badamgarav, Joseph D Croft, Andriana Hohlbauch, James S Louie, James O'Dell, Arthur Weaver

Arthritis Rheum· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating the new rheumatoid arthritis biologic therapies.
Arthur L Weaver

J Clin Rheumatol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis